216 related articles for article (PubMed ID: 8733124)
21. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728
[TBL] [Abstract][Full Text] [Related]
22. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
[TBL] [Abstract][Full Text] [Related]
23. Essential function of NHE8 in mouse retina demonstrated by AAV-mediated CRISPR/Cas9 knockdown.
Xia CH; Ferguson I; Li M; Kim A; Onishi A; Li L; Su B; Gong X
Exp Eye Res; 2018 Nov; 176():29-39. PubMed ID: 29958869
[TBL] [Abstract][Full Text] [Related]
24. Assessment of Adeno-Associated Virus Serotype Tropism in Human Retinal Explants.
Wiley LA; Burnight ER; Kaalberg EE; Jiao C; Riker MJ; Halder JA; Luse MA; Han IC; Russell SR; Sohn EH; Stone EM; Tucker BA; Mullins RF
Hum Gene Ther; 2018 Apr; 29(4):424-436. PubMed ID: 29160116
[TBL] [Abstract][Full Text] [Related]
25. Intraocular adenoviral vector-mediated gene transfer in proliferative retinopathies.
Mori K; Gehlbach P; Ando A; Wahlin K; Gunther V; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1610-5. PubMed ID: 11980881
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of rAAV2-mediated transgene expression in retina cells in vitro and in vivo by coadministration of low-dose chemotherapeutic drugs.
Zhang S; Wu J; Wu X; Xu P; Tian Y; Yi M; Liu X; Dong X; Wolf F; Li C; Huang Q
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2675-84. PubMed ID: 22427581
[TBL] [Abstract][Full Text] [Related]
27. In Vitro Evaluation of AAV Vectors for Retinal Gene Therapy.
Wagner JE; Schön C; Becirovic E; Biel M; Michalakis S
Methods Mol Biol; 2019; 1834():383-390. PubMed ID: 30324456
[TBL] [Abstract][Full Text] [Related]
28. Recombinant AAV-transduced iris pigment epithelial cell transplantation may transfer vector to native RPE but suppress systemic dissemination.
Yoshioka Y; Abe T; Wakusawa R; Moriya T; Mochizuki S; Saigo Y; Saito T; Murata H; Tokita Y; Iseya T; Sugano E; Tomita H; Sagara Y; Tamai M
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):745-52. PubMed ID: 16431976
[TBL] [Abstract][Full Text] [Related]
29. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa.
McGee Sanftner LH; Abel H; Hauswirth WW; Flannery JG
Mol Ther; 2001 Dec; 4(6):622-9. PubMed ID: 11735347
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.
Bemelmans AP; Kostic C; Crippa SV; Hauswirth WW; Lem J; Munier FL; Seeliger MW; Wenzel A; Arsenijevic Y
PLoS Med; 2006 Oct; 3(10):e347. PubMed ID: 17032058
[TBL] [Abstract][Full Text] [Related]
31. AAV
Xiong W; Wu DM; Xue Y; Wang SK; Chung MJ; Ji X; Rana P; Zhao SR; Mai S; Cepko CL
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5785-5794. PubMed ID: 30833387
[TBL] [Abstract][Full Text] [Related]
32. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
[TBL] [Abstract][Full Text] [Related]
33. Ocular gene transfer with self-complementary AAV vectors.
Yokoi K; Kachi S; Zhang HS; Gregory PD; Spratt SK; Samulski RJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3324-8. PubMed ID: 17591905
[TBL] [Abstract][Full Text] [Related]
34. AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa.
Smith AJ; Schlichtenbrede FC; Tschernutter M; Bainbridge JW; Thrasher AJ; Ali RR
Mol Ther; 2003 Aug; 8(2):188-95. PubMed ID: 12907141
[TBL] [Abstract][Full Text] [Related]
35. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
Beltran WA; Cideciyan AV; Boye SE; Ye GJ; Iwabe S; Dufour VL; Marinho LF; Swider M; Kosyk MS; Sha J; Boye SL; Peterson JJ; Witherspoon CD; Alexander JJ; Ying GS; Shearman MS; Chulay JD; Hauswirth WW; Gamlin PD; Jacobson SG; Aguirre GD
Mol Ther; 2017 Aug; 25(8):1866-1880. PubMed ID: 28566226
[TBL] [Abstract][Full Text] [Related]
36. Design and Development of AAV-based Gene Supplementation Therapies for Achromatopsia and Retinitis Pigmentosa.
Schön C; Becirovic E; Biel M; Michalakis S
Methods Mol Biol; 2018; 1715():33-46. PubMed ID: 29188504
[TBL] [Abstract][Full Text] [Related]
37. Triple Vectors Expand AAV Transfer Capacity in the Retina.
Maddalena A; Tornabene P; Tiberi P; Minopoli R; Manfredi A; Mutarelli M; Rossi S; Simonelli F; Naggert JK; Cacchiarelli D; Auricchio A
Mol Ther; 2018 Feb; 26(2):524-541. PubMed ID: 29292161
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus vector-mediated in vivo gene transfer into adult murine retina.
Bennett J; Wilson J; Sun D; Forbes B; Maguire A
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2535-42. PubMed ID: 8163342
[TBL] [Abstract][Full Text] [Related]
39. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.
Bainbridge JW; Mistry A; Schlichtenbrede FC; Smith A; Broderick C; De Alwis M; Georgiadis A; Taylor PM; Squires M; Sethi C; Charteris D; Thrasher AJ; Sargan D; Ali RR
Gene Ther; 2003 Aug; 10(16):1336-44. PubMed ID: 12883530
[TBL] [Abstract][Full Text] [Related]
40. Changes in adeno-associated virus-mediated gene delivery in retinal degeneration.
Kolstad KD; Dalkara D; Guerin K; Visel M; Hoffmann N; Schaffer DV; Flannery JG
Hum Gene Ther; 2010 May; 21(5):571-8. PubMed ID: 20021232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
